Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Mora

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Immunologic Research|July 11, 2001
IL-4 signaling, gene transcription regulation, and the control of effector T cellsM Boothby, A L Mora, M A Aronica, et al.
Parasite Immunology|March 1, 1991
Molecular analysis of HLA DR4-beta 1 gene in malaria vaccinees. Typing and subtyping by PCR technique and oligonucleotidesL A Murillo, C L Rocha, A L Mora, et al.
The Journal of Experimental Medicine|November 17, 1998
In vivo function of an interleukin 2 receptor beta chain (IL-2Rbeta)/IL-4Ralpha cytokine receptor chimera potentiates allergic airway diseaseJ Youn, J Chen, S Goenka, et al.
Vaccine|January 1, 1992
The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivityR Amador, A Moreno, V Valero, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
Preferential role for NF-kappa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivoM A Aronica, A L Mora, D B Mitchell, et al.
Parasite Immunology|September 1, 1991
Genetic control of the immune response to a synthetic vaccine against Plasmodium falciparumM E Patarroyo, J Vinasco, R Amador, et al.
Cell Death and Differentiation|August 23, 2003
Antiapoptotic function of NF-kappaB in T lymphocytes is influenced by their differentiation status: roles of Fas, c-FLIP, and Bcl-xLA L Mora, R A Corn, A K Stanic, et al.
Parasite Immunology|January 1, 1992
Determination of the immunization schedule for field trials with the synthetic malaria vaccine SPf 66C L Rocha, L A Murillo, A L Mora, et al.
The Journal of Infectious Diseases|July 1, 1992
Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trialR Amador, A Moreno, L A Murillo, et al.
Lancet (London, England)|March 20, 1993
Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaM V Valero, L R Amador, C Galindo, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Immunologic Research|July 11, 2001
IL-4 signaling, gene transcription regulation, and the control of effector T cellsM Boothby, A L Mora, M A Aronica, et al.
Parasite Immunology|March 1, 1991
Molecular analysis of HLA DR4-beta 1 gene in malaria vaccinees. Typing and subtyping by PCR technique and oligonucleotidesL A Murillo, C L Rocha, A L Mora, et al.
The Journal of Experimental Medicine|November 17, 1998
In vivo function of an interleukin 2 receptor beta chain (IL-2Rbeta)/IL-4Ralpha cytokine receptor chimera potentiates allergic airway diseaseJ Youn, J Chen, S Goenka, et al.
Vaccine|January 1, 1992
The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivityR Amador, A Moreno, V Valero, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
Preferential role for NF-kappa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivoM A Aronica, A L Mora, D B Mitchell, et al.
Parasite Immunology|September 1, 1991
Genetic control of the immune response to a synthetic vaccine against Plasmodium falciparumM E Patarroyo, J Vinasco, R Amador, et al.
Cell Death and Differentiation|August 23, 2003
Antiapoptotic function of NF-kappaB in T lymphocytes is influenced by their differentiation status: roles of Fas, c-FLIP, and Bcl-xLA L Mora, R A Corn, A K Stanic, et al.
Parasite Immunology|January 1, 1992
Determination of the immunization schedule for field trials with the synthetic malaria vaccine SPf 66C L Rocha, L A Murillo, A L Mora, et al.
The Journal of Infectious Diseases|July 1, 1992
Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trialR Amador, A Moreno, L A Murillo, et al.
Lancet (London, England)|March 20, 1993
Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaM V Valero, L R Amador, C Galindo, et al.
Pageof 3